Response to: ‘ “Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers’ effectiveness in axial spondyloarthritis: results of a prospective, multicentre study” by Moltó et al: still a long way to go in the assessment of patients with spondyloarthritis and concomitant fibromyalgia?’ by Altobelli et al